Background. Excessive alcohol consumption is a risk factor for hypertension and stroke; however, evidence for an association with chronic kidney disease is conflicting. Methods. A total of 6259 adults ≥25 years of age, without a history of alcohol dependence, participating in baseline (1999)(2000) and follow-up (2004-2005) phases of an Australian population-representative study (AusDiab) were the subject of this analysis. Alcohol consumption status and volume/frequency were collected by standardized interviewer administered questionnaires and self-administered food frequency questionnaires. The outcomes were as follows: (i) 5-year decline in estimated glomerular filtration rate (eGFR) ≥10%, with baseline eGFR ≥ 60 and final eGFR <60 mL/min/1.73 m 2 , and (ii) 5-year doubling of albumin to creatinine ratio (ACR) with final ACR ≥ 2.5 (males)/≥ 3.5 (females) mg/mmol, in the absence of albuminuria at baseline. Results. Self-identification as a moderate or heavy, versus light, drinker was associated with elevated risk of albuminuria in males and females <65 years of age (OR, 95% CI: males 1.87, 0.99-3.52; females 2.38, 1.37-4.14). Odds of de novo eGFR <60 mL/min/1.73 m 2 were 0.34 (95% CI 0.22-0.59) and 0.68 (95% CI 0.36-1.27) in males and females, respectively, who were moderate-heavy drinkers. Alcohol intake of ≥30 g/day was associated with an increased risk of albuminuria after adjustment for age, sex and baseline kidney function (OR = 1.59, 95% CI 1.07-2.36), but a reduced risk of eGFR <60 mL/min/1.73 m 2 (OR = 0.59, 95% CI 0.37-0.95), compared with consumption of <10 g/day. Conclusions. Moderate-heavy alcohol consumption may be an important modifiable risk factor for albuminuria in the general population. The natural history of alcoholinduced kidney damage and how this relates to markers of kidney function in the general population warrant further research.
Introduction
Long-term excessive alcohol consumption is an established risk factor not only for numerous chronic diseases, particularly liver disease and cancer but also for vascular diseases including hypertension and stroke [1] . The relationship between alcohol consumption and chronic kidney disease (CKD) has, however, been the subject of relatively little research. Experimental evidence supports a direct, acute nephrotoxic effect of alcohol on the kidney [2] ; alternatively, chronic use in humans may result in alcohol-induced hypertension [3, 4] , indirectly increasing the risk of CKD. In specific circumstances, alcohol abuse or dependence has been linked to particular renal pathologies, including renal papillary necrosis, infection-associated glomerulonephritis and acute renal failure due to non-traumatic rhabdomyolysis [5] [6] [7] .
Prospective population-based studies have linked heavy alcohol consumption with incidence of CKD [8, 9] . However, recent studies have reported an inverse relationship between alcohol consumption and CKD risk [10, 11] . On the basis of largely contradictory epidemiological evidence from a small number of existing prospective studies, it is difficult to reach conclusions regarding the consequences of excessive alcohol consumption for the kidney. Therefore, using 5-year longitudinal data from a prospective, population-representative, cohort study, we have explored the relationship between alcohol consumption and the onset of CKD, defined according to both albumin to creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR), to better understand the relationship between alcohol consumption and kidney disease in the general population. Low eGFR at baseline n = 452 * Requested no further contact, moved to a high-care nursing facility or ineligible due to chronic or terminal illness
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Subjects and methods
The Australian Diabetes, Obesity and Lifestyle study (AusDiab) is a national, population-based, longitudinal survey of diabetes mellitus and associated risk factors in Australians ≥25 years of age, which commenced in 1999. Detailed survey methods and specific measurement procedures are reported elsewhere [12, 13] . Of the original cohort (n = 11 247), 10 788 participants were eligible for the 5-year follow-up in [2004] [2005] . Of these, 6537 (60.6%) returned for follow-up assessment ( Figure 1 ). The current analysis examines the risk of longitudinal outcomes in the 6259 individuals participating in both baseline and follow-up examinations with complete data on outcomes and relevant covariates under study. Individuals who identified themselves as having been treated for alcohol dependence in the past were excluded from this analysis, as the risk of morbidity attributable to alcohol consumption in this group is likely to relate to past rather than current drinking patterns at the time of assessment (n = 61, <1%). The ethics committee of the International Diabetes Institute approved the study and informed consent was obtained from all participants. Both the baseline and follow-up assessments followed a similar protocol. Those who attended testing sites underwent a physical examination that included blood pressure measurements, assessment of waist circumference, height and weight, collection of blood by venipuncture following an overnight fast, collection of a random spot morning urine specimen and a standard 75 g oral glucose tolerance test. Blood and urine samples were transferred to a central laboratory for analysis (baseline: HITECH Pathology, Clayton, Victoria; follow-up: Gribbles Pathology, Clayton, Victoria).
Urine albumin and creatinine were measured on a morning spot urine sample. At baseline, spot urine creatinine was measured using the modified kinetic Jaffe reaction using an Olympus AU600 auto-analyser and urine albumin measured by rate nephelometry using a Beckman Array (Beckman/ Coulter, Sydney, Australia). At follow-up, spot urine creatinine was measured using the Jaffe spectrophotometric alkaline picrate method on a Roche Modular (Roche Diagnostics), and urine albumin was measured by nephelometry on a Beckman Immage (Beckman Coulter, Inc.). Serum creatinine was measured at baseline and 5-year follow-up by the modified kinetic Jaffe reaction, using the Olympus AU600 auto-analyser at baseline, and in 2004-2005 using the Roche Modular. Serum creatinine was subsequently calibrated by the Isotope Dilution Mass Spectrometry (IDMS) method by re-assaying stored subsamples from both surveys (baseline n = 239, follow-up n = 295) at Monash Medical Centre (Beckman/Coulter, Sydney, Australia). GFR was estimated using the 're-expressed' Modification of Diet in Renal Disease (MDRD) study prediction formula using the calibrated serum creatinine values [14] .
At baseline and follow-up, trained interviewers administered standardized questionnaires which collected information regarding demographic characteristics, educational attainment, smoking habits, physical activity during the previous week, existing health conditions under management and current use of medications. Known diabetes was defined as current use of insulin or tablets or, for diet-controlled individuals, either a fasting or a post-load glucose value in the diabetic range. Current use of blood pressure lowering medication was defined as an affirmative response to the question: 'Are you currently taking tablets for high blood pressure?'; the brand/type of tablets was not asked. Physical activity time was calculated as the total time spent walking or performing moderate-intensity physical activity, plus double the time spent in vigorous-intensity physical activity, in the week preceding the survey.
Interviewer-administered questionnaires also contained questions regarding alcohol consumption status. The participants were asked: 'In terms of drinking alcohol, which category would you generally put yourself in?' given the response options (i) I have never drunk alcohol; (ii) I used to drink but gave it up; (iii) I'm a heavy drinker; (iv) I'm a moderate drinker or (v) I'm a light drinker. The participants were also asked: 'Have you ever considered yourself a heavy drinker?' From these data, current drinking was defined by self-categorization as a light/moderate/heavy drinker; non-drinkers were defined as those respondents who reported having never drunk alcohol or having given up alcohol. Current/former heavy drinking was defined by self-categorization as a current heavy drinker, or an affirmative response to the question: 'Have you ever considered yourself a heavy drinker?' Further information regarding frequency and volume of alcohol consumption was collected using a self-administered validated Food Frequency Questionnaire (FFQ) developed by the Anti-Cancer Council of Victoria [15] . The participants were asked: 'Over the last 12 months, how often did you drink beer, wine and/or spirits?' with response options ranging from never to every day and 'Over the last 12 months, on days when you were drinking, how many glasses of beer, wine and/or spirits altogether did you drink?' with response options ranging from 1 to ≥10. The participants were prompted to convert the amount they usually consumed into standard drinks with the help of conversion examples. Data from the self-administered FFQ were converted into a continuous measure expressed in grams of ethanol per day [16] . The distribution of this measure was highly right-skewed; hence, for the statistical analyses alcohol consumption among current drinkers was divided into categories of average daily intake. These categories were defined as (i) <10 g/day (reference group), excluding non-drinkers who also reported a zero alcohol intake on the FFQ; (ii) ≥10 and <30 g/day, representing moderate risk; and (iii) ≥30 g/day, representing high-risk individuals [17] .
Comparisons between the baseline characteristics of non-drinkers versus current drinkers were performed adjusted for age and stratified by sex, using Wald χ 2 tests for categorical variables and F-tests for continuous variables. Separate logistic analyses assessed the associations between categories of alcohol consumption at baseline and 5-year risk of (i) de novo eGFR <60 mL/min/1.73 m 2 , defined as a 5-year decline in eGFR of ≥10% with eGFR ≥60 mL/min/1.73 m 2 at baseline, and a final eGFR <60 mL/min/1.73 m 2 (at risk = 5807), and (ii) de novo albuminuria, defined as a doubling of ACR over 5 years with a final ACR ≥ 2.5 in males and ≥3.5 mg/mmol in females, in the absence of albuminuria at baseline (at risk = 5923). Logistic regression models were constructed for the overall sample and also with the exclusion of participants ≥65 years at baseline, to account for potential confounding by increased rates of illness-related abstinence with advancing age. All regression models were initially adjusted for age at baseline, sex (in models not stratified for sex) and kidney function (eGFR or the natural logarithm of ACR as continuous variables) at baseline. For all analyses, the lowest level of alcohol consumption was taken as the reference category, rather than non-drinkers, as the risk profile of abstainers was expected to be distinct from that of low-risk drinkers. The participants who reported having been treated for alcohol dependence in the past were excluded from the current analysis, as the risk of morbidity attributable to alcohol consumption in this population was likely to be related to former rather than current drinking patterns at baseline. Standard errors of all logistic and multiple linear regression coefficients were corrected for the stratified-cluster sample design of the survey, to account for potential intra-cluster correlation. Standard errors were adjusted according to applicable cluster and strata at baseline, not taking into account subsequent movement between clusters or strata. All analyses were performed using Stata Statistical Software Version 9.2 (College Station, TX, USA). Table 1 gives the baseline characteristics of the 6259 individuals (2810 males and 3449 females) participating in both baseline and follow-up examinations with complete data on all required variables and without a history of alcohol dependence. At baseline, 11.5% of males (n = 324) reported having never drunk alcohol or having given up drinking, compared with 17.7% (n = 609) of females. Most males and females who reported being current drinkers at a All proportions and ORs adjusted for age at baseline and the natural logarithm of the baseline albumin to creatinine ratio as continuous variables.
Results
baseline categorized themselves as light drinkers (59.7% and 81.6%, respectively). A significant minority categorized themselves as moderate (males 37.5%, females 17.8%) but few as heavy drinkers, only 2.78% of males (n = 69) and 0.60% of females (n = 17). Given the small number of males and females identifying themselves as heavy drinkers at baseline, those with moderate and heavy alcohol consumption status were grouped into a single risk category in subsequent analyses. For both males and females, the age distribution of non-drinkers at baseline significantly differed from that of current drinkers such that 25-44 year olds were heavily represented among current drinkers, whereas individuals aged ≥65 years were represented more often among nondrinkers. Current drinkers tended to have higher rates of high-school completion (age-adjusted P-values: males = 0.056; females <0.001) and of sufficient physical activity (males: P <0.001; females: P = 0.001), but were more often smokers than non-drinkers (males: P = 0.050; females: P = 0.143). The prevalence of chronic conditions, including known diabetes, treated hypertension or a prior cardiovascular event, was lower among current drinkers compared with non-drinkers, an observation which was only partly explained by age.
Of the prospective sample of 6259 individuals, 336 were detected as having albuminuria at baseline, leaving a total of 5923 at risk of de novo albuminuria in 2004-2005 (see Figure 1) . Table 2 shows the results of logistic regression analyses of the associations between self-identified category of alcohol consumption at baseline and 5-year risk of de novo albuminuria. After adjustment for age and the natural logarithm of ACR at baseline, females who identified themselves as moderate or heavy drinkers at baseline were significantly more likely to develop albuminuria over 5 years, compared with light drinkers (all females: OR = 1.75, 95% CI 1.06-2.90; <65 years: OR = 2.38, 95% CI 1.37-4.14). Similar trends were observed for males (all males: OR = 1.16, 95% CI 0.78-1.72; <65 years: OR = 1.87, 95% CI 0.99-3.52). To exclude the possibility that these results were driven entirely by the small number of males and females who identified themselves as heavy drinkers, analyses were repeated retaining moderate alcohol consumption status as a discrete category. Females who identified themselves as moderate drinkers remained significantly more likely to develop albuminuria compared with light drinkers (all females: OR = 1.81, 95% CI 1.09-3.00; <65 years: OR = 2.47, 95% CI 1.43-4.28). Effects were attenuated in males (all males: OR = 1.05, 95% CI 0.68-1.63; <65 years: OR = 1.69, 95% CI 0.87-3.27).
Despite small numbers, self-reported current or former heavy drinking was also significantly associated with risk of de novo albuminuria in females (OR = 2.24, 95% CI 1.00-5.01). There was some evidence of increased risk of developing albuminuria in males <65 years who reported having given up alcohol, versus light drinkers, although the number in this category was small and the result was non-significant (OR = 2.74, 95% CI 0.90-8.35). In contrast, having given up alcohol was associated with a non-significant reduction of risk, versus light drinking, in females.
There were 5807 males and females at risk of de novo eGFR <60 mL/min/1.73 m 2 (Table 3) . After adjusting for age and baseline eGFR, identification as a moderate or heavy drinker was associated with a reduced likelihood of de novo eGFR<60 mL/min/1.73 m 2 , compared with light drinkers (males: OR = 0.67, 95% CI 0.51-0.89; females: OR = 0.78, 95% CI 0.45-1.34). In subgroup analysis of males <65 years, risk of de novo eGFR <60 mL/min/1.73 m 2 among moderate/heavy versus light drinkers was reduced by nearly 65% (OR = 0.36, 95% CI 0.22-0.59). A similar but non-significant trend was observed for females <65 years (OR = 0.68, 95% CI 0. 36-1.27) . No significant associations with risk of de novo eGFR <60 mL/min/ 1.73 m 2 were observed for any of the other alcohol consumption categories. Analysis of self-categorized moderate drinkers as a discrete group gave almost identical results to the analysis of moderate and heavy drinkers combined. The age-and baseline eGFR-adjusted odds of de novo eGFR <60 mL/min/1. The results for alcohol exposure measured by the FFQ are presented in Tables 4 and 5 . After adjustment for age, sex and the natural logarithm of baseline albumin to creatinine ratio, consumption of ≥30 g of ethanol per day was associated with a significantly increased risk of de novo albuminuria overall (OR = 1.59, 95% CI 1.07-2.36), and particularly in the subgroup <65 years (OR = 2.31, 95% CI 1.38-3.86). Point estimates were similar for males and females analysed separately, though statistical power was reduced. In models adjusted for established hypertension and systolic blood pressure, observed associations were attenuated although stull significant for the subgroup <65 years of age. Associations were also robust to additional adjustment for established diabetes, HbA1c and lifestylerelated factors (baseline smoking, physical activity habits and waist to hip ratio). Table 5 shows that consumption of ≥30 g of ethanol per day, versus <10 g, was associated with a 40% reduction in the likelihood of de novo eGFR<60 mL/min/1.73 m 2 for the overall population at risk, after adjustment for age, sex and baseline eGFR(OR = 0.59, 95% CI 0.37-0.95). Results were equivalent when adjusted for additional biomedical or lifestyle factors. Associations were stronger in subgroup analyses of <65 year olds. Figure 2 shows the proportion, adjusted for age, sex and baseline kidney function, of the study population with de novo albuminuria and de novo eGFR <60 mL/min/1.73 m 2 within each group for alcohol consumption (in g/day at baseline). These plots suggest that, in this cohort, the risk of albuminuria begins to increase at an average ethanol intake of 30 g/day, whereas ethanol intake has an inverse, approximately linear, relationship with the risk of onset of eGFR < 60 mL/min/1.73 m 2 .
Discussion
In this prospective study of Australian adults, selfcategorization as a moderate or heavy drinker or an average consumption of 30 g of ethanol per day or more was associated with significantly elevated risks of developing albuminuria over 5 years of follow-up, compared with a Non-drinkers excluded from the reference group, non-drinkers defined as self-reported alcohol consumption status of 'I have never drunk alcohol' or 'I used to drink but gave it up' and a volume/frequency of alcohol consumption of 0 g/day as reported in the FFQ. * P < 0.1. * * P < 0.05. * * * P < 0.01. Model 1: adjusted for age at baseline, sex (except sex-stratified models) and the natural logarithm of baseline ACR. Model 2: adjusted for variables in Model 1 and use of blood pressure lowering medication at baseline and for the average of baseline and follow-up values of systolic blood pressure. Model 3: adjusted for variables in Model 2 and for diabetes at baseline (defined as use of insulin or tablets, or, for diet-controlled individuals, as a fasting or post-load glucose value in the diabetic range) and for the average of baseline and follow-up values of HbA1c. Model 4: adjusted for variables in Model 3 and for current smoking at baseline, physical activity category at baseline (inactive, >0-150 min/week or >150 min/week physical activity) and for the waist to hip ratio as a continuous variable, baseline and follow-up values averaged. a Non-drinkers excluded from the reference group, non-drinkers defined as self-reported alcohol consumption status of 'I have never drunk alcohol' or 'I used to drink but gave it up' and a volume/frequency of alcohol consumption of 0 g/day as reported in the FFQ. * P < 0.1. * * P < 0.05. * * * P < 0.01. light alcohol consumption. Similar effects were observed for males and females when analysed separately although effects were strongest in the group younger than 65 years at baseline. Changing lifestyles with age and ill health are likely to underlie this age-related effect. Adjustment for treated hypertension, systolic blood pressure, established diabetes, glucose control and for lifestyle factors linked with alcohol consumption, including smoking, physical inactivity and body composition, only partially accounted for the increased risk of albuminuria associated with excessive alcohol consumption. In contrast, moderate to heavy alcohol consumption was associated with a reduced risk of developing an eGFR < 60 mL/min/1.73 m 2 over the 5-year follow-up period. This result was similarly robust to confounding by diabetes, hypertension and lifestyle risk factors. In the population younger than 65 years, alcohol consumption of 30 g or more daily was associated with a >50% reduction in the likelihood of new onset low eGFR.
These findings are simultaneously consistent with previous reports linking moderate to heavy alcohol consumption with increased urinary albumin excretion [18, 19] and with several studies reporting an inverse relationship between alcohol consumption and risk of serum creatinine-based outcomes [11, 20, 21] . Analysis of data from the Physicians Health Study indicated that men who consumed at least seven drinks per week had a 30% decreased risk of developing CKD over 14 years compared with men who consumed no more than one drink per week [11] . Kronborg et al. reported that, among males, consumption of seven or more units of alcohol per week was associated with a significant increase in eGFR over 7 years of follow-up versus abstinence although the same was not observed for females, and effects disappeared when controlled for the presence of diabetes or cardiovascular disease [21] . Data from the Nurses' Health Study indicated no long-term adverse effect of moderate alcohol consumption on eGFR in females [22] . The proposed biological mechanisms for a protective effect of alcohol on the kidney include beneficial effects on cardiovascular risk factors such as HDL cholesterol subfraction levels [23, 24] , a correlation with hyalinization of renal arterioles [25] and a possible reduction in the risk of type 2 diabetes [26] and of arteriosclerosis associated with type 2 diabetes [27] .
In this analysis, whilst the lowest risk of de novo eGFR <60 mL/min/1.73 m 2 was found among those reporting the highest alcohol consumption at baseline, their risk of developing albuminuria over the same interval was at least 50% greater than that among light drinkers, an observation that is at odds with a renoprotective effect. One possible explanation relates to the serum creatinine-based method of GFR estimation. Serum creatinine concentration is influenced by a number of factors unrelated to kidney function, but which may be related to alcohol consumption, such as diet, total muscle mass, muscle metabolism, inflammatory disease and decreased creatinine production as a result of liver damage [28] , introducing varying degrees of measurement bias in the estimation of GFR. Such an effect is best documented in cirrhosis [29, 30] ; however, the extent to which these factors affect accurate measurement of serum creatinine in the general population is unknown.
Regardless of whether our results for the eGFR-based outcome represent a true biological effect, albuminuria alone is an important marker of kidney outcomes in the general population [31, 32] . The PREVEND investigators observed that macroalbuminuria was in fact a better predictor of accelerated loss of kidney function over a 4-year period than low eGFR [33] . Furthermore, microalbuminuria is a robust independent predictor of cardiovascular events and all-cause mortality [34, 35] and is associated with elevated cardiovascular risk across the entire range of eGFR [36] .
For the present analyses we took the lowest alcohol consumption group as the reference category, excluding non-drinkers. The choice of reference category is significant; low-risk drinking is the major public health goal for the prevention of alcohol-related harm and is normative in our source population. Non-drinkers, who formed a minority in this analysis, were characterized by a high prevalence of diabetes, treated hypertension and prior cardiovascular events, and therefore do not represent and appropriate, low-risk reference group. Furthermore, even after controlling for confounders, low-risk drinking has been linked with reduced cardiovascular risk compared with abstinence [37] . There is similar evidence that low-moderate alcohol consumption confers protection against development and progression of CKD [9, 38] . In their case-control study, Perneger et al. demonstrated a J-shaped relationship between alcohol consumption and odds of ESKD [9] , while Yamagata et al. observed in a prospective study of CKD that an alcohol intake of <20 g/day reduced the risk of developing CKD compared to abstinence [38] . Similarly, we observed a non-significant increase in odds of de novo albuminuria among self-reported lifelong abstainers versus light drinkers although numbers were small particularly among males.
Reliability and validity of exposure ascertainment are the primary limitations of this analysis. Selective reporting and deliberate under-reporting by heavy drinkers may introduce serious bias. However, the Graduated Frequency method, applied in this study, is demonstrated to encourage fuller reporting of alcohol consumption [39] . Still, however, questions regarding usual number of drinks consumed are noted to suffer from bias towards occasions of low consumption, and may be additionally confounded by the disparity between a typical serving and one standard drink [40] . In the FFQ, participants were asked to estimate the quantity of consumption according to standard drinks, a concept that is relatively well established in Australia [41] . However, underestimation of alcohol intake is still likely. In terms of self-categorization of the alcohol consumption status during interviewer-administered questionnaires, social desirability may be a significant factor influencing responses, and indeed, effects were weaker than those for the analysis of FFQ-measured exposure. Also a level of consumption considered 'moderate' by study participants may not correlate with moderate risks to health. Finally, bias may be introduced due to difficulties in contacting heavier drinkers through household surveys, non-response, selective loss to follow-up and forgetfulness on the part of drinkers [39] .
The principal strengths of this analysis are the prospective study design, the level of detail in the measurement of alcohol consumption including use of the Graduated Frequency method, the exclusion of alcoholics and the stringent capture of potential confounders including diabetes, hypertension and smoking. On an international level, Australia ranks towards the middle of high-income countries in terms of recorded adult per capita consumption of alcohol, ahead of Norway, Sweden, Canada and the USA although behind the UK, Germany and France [1] . Our findings are broadly generalizable although the population effects of excessive alcohol consumption on CKD will vary where alcohol consumption level, patterns of consumption and characteristics of chronic drinkers differ to those described here.
In conclusion, in this prospective cohort, the risk of developing new onset albuminuria began to rise for an average daily alcohol consumption of 30 g or more, or approximately three standard drinks. At the same threshold, the risk of developing a low eGFR was significantly reduced. Alcohol consumption, particularly heavy drinking, is likely to be a significant modifiable risk factor for the development of albuminuria. However, neither the biological mechanism by which alcohol induces kidney damage not the natural history of this process and its relationship with markers of kidney function in the general population is truly understood, and further research into these mechanisms is warranted.
